August 10, 2007 (Rockville, MD) - The FDA is reviewing the safety of omeprazole (Prilosec, AstraZeneca) and esomeprazole (Nexium, AstraZeneca), proton-pump inhibitors used for the treatment of ...
In patients with gastroesophageal reflux disease (GERD), esomeprazole, has demonstrated pharmacological and clinical benefits beyond those seen with the other proton pump inhibitors( PPIs ). However ...
April 10, 2009 (Munich, Germany) — A new study using platelet-aggregometry testing to assess the effects of different proton-pump inhibitors (PPIs) on platelet response to clopidogrel suggests that ...
The U.S. Food and Drug Administration has received and is reviewing new safety data about two popular heartburn medications -- Prilosec (omeprazole) and Nexium (esomeprazole). On May 29, 2007, ...
Prescription_writing Advice of regulatory authorities released in 2009 and 2010 regarding safety concerns for concomitant use of clopidogrel and certain proton pump inhibitors (PPIs) was partially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results